A decade of non‐invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testing

Abstract excerpt

Prenatal screening for aneuploidy has undergone immense changes over the past two decades. In 2013 cell-free DNA-based non-invasive prenatal testing (NIPT) became a new self-funded option primarily for Down syndrome screening, but also other aneuploidies and genetic conditions. The numbers of Medicare item claims for prenatal diagnostic procedures have halved since the introduction of NIPT, while billings for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Parvovirus B19 Infection Studies
• Share to Prenatal Screening and Diagnostics